Spark Biomedical, Inc. is honored to speak at Congressman Dan Crenshaw's (R-TX) Third Annual Healthcare Innovation Summit on Friday, July 23, 9:00 a.m. – 11:30 a.m. CT at Rice University.

Spark Biomedical, Inc, CARMAhealth, and Recovery Unplugged jointly developed abstract places second in the American Society of Pain and Neuroscience (ASPN) 2020 Annual Conference. The abstract entitled, Interim Results from a Randomized, Double-Blind, Controlled Trial Examining Use of Transcutaneous Auricular Neurostimulation (tAN) to Improve Symptoms Associated with Opioid Withdrawal, outlines initial results from the first 20 patients in the clinical trial targeting participants with opioid use disorder.

The highlight of the 2020 NANS session was a competition among 12 new and emerging firms in the neuromodulation industry. Each entrepreneur was give 10 minutes to present and then field questions from the judges and the audience in an effort to win cash prizes and “Best in Show.”

We invite you to join Spark Biomedical, Inc. as we present and exhibit at the North American Neuromodulation Society 23rd Annual Conference, Las Vegas, NV at Caesar’s Palace.

College Station, TX, May 3, 2019 — As Texas A&M New Ventures Competition 2019 #TNVC2019 approaches, May 15 – 17, the semi-finalist list has been announced. Spark Biomedical, Inc. is proud to be listed among the esteemed semi-finalists. Aimed at promoting the commercialization of emerging technology, the competition recognizes companies with high-growth potential and provides seed funding to help them effectively execute their ideas and advance product development.